JP2007536920A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536920A5 JP2007536920A5 JP2007512116A JP2007512116A JP2007536920A5 JP 2007536920 A5 JP2007536920 A5 JP 2007536920A5 JP 2007512116 A JP2007512116 A JP 2007512116A JP 2007512116 A JP2007512116 A JP 2007512116A JP 2007536920 A5 JP2007536920 A5 JP 2007536920A5
- Authority
- JP
- Japan
- Prior art keywords
- mammal
- expression
- responsive
- cell proliferative
- receptor antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000124008 Mammalia Species 0.000 claims 25
- 230000014509 gene expression Effects 0.000 claims 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 13
- 230000026731 phosphorylation Effects 0.000 claims 13
- 238000006366 phosphorylation reaction Methods 0.000 claims 13
- 230000002062 proliferating effect Effects 0.000 claims 13
- 210000004027 cell Anatomy 0.000 claims 12
- 238000000034 method Methods 0.000 claims 10
- 229940124090 Platelet-derived growth factor (PDGF) receptor antagonist Drugs 0.000 claims 9
- 238000002651 drug therapy Methods 0.000 claims 8
- 230000002068 genetic effect Effects 0.000 claims 8
- 238000000338 in vitro Methods 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 239000002299 complementary DNA Substances 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003550 marker Substances 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 238000000018 DNA microarray Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0410883A GB0410883D0 (en) | 2004-05-14 | 2004-05-14 | Organic compounds |
| GB0425257A GB0425257D0 (en) | 2004-11-16 | 2004-11-16 | Organic compounds |
| PCT/EP2005/005269 WO2005113801A2 (en) | 2004-05-14 | 2005-05-13 | Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007536920A JP2007536920A (ja) | 2007-12-20 |
| JP2007536920A5 true JP2007536920A5 (enExample) | 2008-07-03 |
Family
ID=35295424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007512116A Pending JP2007536920A (ja) | 2004-05-14 | 2005-05-13 | イマチニブを用いる処置に感受性のある膠芽腫の小集団の同定および特性化 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080199855A1 (enExample) |
| EP (1) | EP1756306A2 (enExample) |
| JP (1) | JP2007536920A (enExample) |
| AU (1) | AU2005245572B9 (enExample) |
| BR (1) | BRPI0511088A (enExample) |
| CA (1) | CA2564654A1 (enExample) |
| MX (1) | MXPA06013079A (enExample) |
| RU (1) | RU2006144122A (enExample) |
| WO (1) | WO2005113801A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2132336A1 (en) * | 2007-03-02 | 2009-12-16 | Board of Regents, The University of Texas System | Multigene assay to predict outcome in an individual with glioblastoma |
| BR112012004237A8 (pt) * | 2009-08-25 | 2016-10-04 | Berg Pharma Llc | métodos para tratamento de um sarcoma usando um alterador epimetabólico (coenzima q10) |
| EA201691257A1 (ru) * | 2011-06-02 | 2017-02-28 | Олмак Дайэгностикс Лимитед | Молекулярно-диагностический тест на рак |
| HK1214633A1 (zh) | 2012-12-03 | 2016-07-29 | Almac Diagnostics Limited | 癌症的分子诊断测试 |
| GB201409479D0 (en) | 2014-05-28 | 2014-07-09 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2829154B1 (fr) * | 2001-09-05 | 2003-10-17 | Assist Publ Hopitaux De Paris | Nouveau procede de detection d'une mutation en phase de lecture dans une sequence codante et appareil pour sa mise en oeuvre |
| WO2003087404A1 (en) * | 2002-04-17 | 2003-10-23 | Novartis Ag | Methods to predict patient responsiveness to tyrosine kinase inhibitors |
| JP4035600B2 (ja) * | 2002-05-22 | 2008-01-23 | 国立大学法人 東京大学 | イマチニブに対する感受性の判定方法 |
-
2005
- 2005-05-13 EP EP05741985A patent/EP1756306A2/en not_active Withdrawn
- 2005-05-13 BR BRPI0511088-2A patent/BRPI0511088A/pt not_active IP Right Cessation
- 2005-05-13 AU AU2005245572A patent/AU2005245572B9/en not_active Expired - Fee Related
- 2005-05-13 CA CA002564654A patent/CA2564654A1/en not_active Abandoned
- 2005-05-13 US US11/568,781 patent/US20080199855A1/en not_active Abandoned
- 2005-05-13 MX MXPA06013079A patent/MXPA06013079A/es not_active Application Discontinuation
- 2005-05-13 JP JP2007512116A patent/JP2007536920A/ja active Pending
- 2005-05-13 RU RU2006144122/13A patent/RU2006144122A/ru not_active Application Discontinuation
- 2005-05-13 WO PCT/EP2005/005269 patent/WO2005113801A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6364488B2 (ja) | 認知欠損を治療するための個別化医療的手法 | |
| Chang et al. | Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model | |
| Choy et al. | Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways | |
| Pertl et al. | C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy | |
| Chahine et al. | Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations | |
| Hu et al. | Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment | |
| Keizman et al. | Low‐grade systemic inflammation in patients with amyotrophic lateral sclerosis | |
| Limdi et al. | Influence of kidney function on risk of supratherapeutic international normalized ratio–related hemorrhage in warfarin users: a prospective cohort study | |
| Posadas-Sánchez et al. | Interleukin 35 polymorphisms are associated with decreased risk of premature coronary artery disease, metabolic parameters, and IL‐35 levels: The genetics of atherosclerotic disease (GEA) study | |
| JP6228302B2 (ja) | プライマリーケアセッティングにおいて神経学的疾患を検出するための血液に基づくスクリーニング | |
| US8158374B1 (en) | Quantitative diagnostic methods using multiple parameters | |
| US20110213219A1 (en) | Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression | |
| Patel et al. | Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning | |
| JP2008537474A5 (enExample) | ||
| O'Bryant et al. | Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study | |
| Assis et al. | A macrophage migration inhibitory factor polymorphism is associated with autoimmune hepatitis severity in US and Japanese patients | |
| Zhu et al. | Genome-wide detection of m6A-associated genetic polymorphisms associated with ischemic stroke | |
| CN116206776A (zh) | 一种多基因snp位点介导的抗精神病药物血药浓度的预测模型及其构建方法和应用 | |
| Baos et al. | Biomarkers associated with disease severity in allergic and nonallergic asthma | |
| Kavalar et al. | Association of ORMDL3, STAT6 and TBXA2R gene polymorphisms with asthma | |
| Neubauer et al. | Diagnostic Potential of Systemic Eosinophil‐Associated Cytokines and Growth Factors in IBD | |
| Zhang et al. | Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array | |
| Tabouret et al. | Predictive biomarkers investigated in glioblastoma | |
| JP2007536920A5 (enExample) | ||
| Kuhlmann et al. | The applications of biomarkers in early clinical drug development to improve decision-making processes |